FDA approves primarily generic versions of Zyprexa
WASHINGTON — Federal strength officials on Monday official the firstly generic versions of the blockbuster drug Zyprexa, an expensive medicine in support of schizophrenia and bipolar mood disorder.Zyprexa posted sales of $5.7 billion keep on time in favor of drugmaker Eli Lilly & Co Inc., according to prescription tracking company IMS vigor.The up-to-the-minute low-cost versions of the drug pray come to pass marketed by Indian generic drugmaker Dr. Reddys Laboratories and by Teva Pharmaceutical Industries, based concerning Israel.